The Explosive Growth of Molecular Diagnostics

Within the South Korea Clinical Laboratory Services Market, molecular diagnostics stands out as the fastest-growing and most dynamic segment. It is projected to achieve a notable CAGR of 9.2% by 2030, driven by continuous technological advancements and a growing clinical utility. This segment includes a wide range of tests, from PCR-based assays for infectious diseases to next-generation sequencing (NGS) for cancer and rare genetic disorders. The increasing focus on personalized medicine and targeted therapies is a primary catalyst for this growth, as molecular diagnostics provides the detailed genetic information required to select the most effective treatment for a patient. The South Korean government’s support for genomic research and the private sector's investment in advanced testing platforms are further accelerating the expansion of this high-value segment.

Link: Understand the future of molecular diagnostics in the market

FAQs

• What is driving the growth of this segment? The segment's growth is driven by advancements in technology like NGS and the increasing demand for personalized medicine and targeted therapies.

• What are the key applications? Key applications include the diagnosis of infectious diseases, cancer profiling, and the detection of rare genetic disorders.